SCHEMBL4583207

SCHEMBL4583207

CC(C)(C)[C@](CN)(Cc1ccccc1)NC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.50
CYP1A2 P05177 3/20 0.50
RECQL P46063 2/20 0.50
MAPK1 P28482 1/20 0.49
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP2D6 P10635 3/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
HIF1A Q16665 1/20 0.43
SLC6A2 P23975 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
MMP8 P22894 4/20 0.42
LMNA P02545 1/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
PRMT1 Q99873 1/20 0.38
OPRM1 P35372 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4073210 0.85 CYP3A4 (0.46) CYP3A4CYP1A2RECQLMAPK1CYP2C9
SCHEMBL1273081 0.85 CYP3A4 (0.46) CYP3A4CYP1A2RECQLMAPK1CYP2C9
SCHEMBL16757585 0.83 CYP2C9 (0.44) CYP3A4CYP1A2RECQLMAPK1CYP2C9
SCHEMBL4027524 0.80 CYP3A4 (0.53) CYP3A4CYP1A2RECQLMAPK1CYP2C9
SCHEMBL2447162 0.76 CYP3A4 (0.50) CYP3A4CYP1A2RECQLMAPK1CYP2C9
SCHEMBL4583697 0.76 KMT2A (0.48) CYP3A4CYP2C9CYP2C19ALDH1A1NPC1
SCHEMBL5948337 0.75 CYP3A4 (0.67) CYP3A4CYP1A2RECQLMAPK1CYP2C9
SCHEMBL17028984 0.74 ALDH1A1 (0.42) CYP3A4CYP1A2RECQLMAPK1CYP2C9
SCHEMBL3725498 0.74 KDM4E (0.51) ALDH1A1SMN1; SMN2NPC1MAPTRAB9A
SCHEMBL4596217 0.73 NPC1 (0.45) CYP3A4CYP1A2CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968568-A2 INHIBITORS OF Akt ACTIVITY SmithKline Beecham Corporation (US) 2008-09-17 EP disclosed
WO-2007076423-A2 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2007-07-05 WO disclosed